Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × olaparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 23 Breast Neoplasms 21 Fallopian Tube Neoplasms 13 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 8 Neoplasms 6 Endometrial Neoplasms 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 3 Lymphoma, Non-Hodgkin 3 Glioma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioblastoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡